Products

DoseMeRx
DoseMe
Pharmacology & Dosing AI
DoseMeRx is the world’s first and largest Bayesian dosing platform, providing individualized drug doses using clinically-validated pharmacokinetic models and patient data to improve patient outcomes and lower costs.

See all 1 product →

About DoseMe

DoseMeRx is a leading healthcare AI company specializing in Model Informed Precision Dosing (MIPD) software. Their platform leverages clinically validated pharmacokinetic/pharmacodynamic (PK/PD) models, patient characteristics, drug concentrations, and, in some cases, genotype to accurately individualize medication doses in real-time. This advanced Bayesian dosing approach aims to optimize therapeutic drug monitoring (TDM) workflows, reduce the incidence of adverse drug events such as toxicity and acute kidney injury, and ultimately improve patient outcomes.

The DoseMeRx platform is designed for ease of use by clinicians and pharmacists, integrating seamlessly with existing electronic health records (EHRs) and pharmacy surveillance software. It provides real-time clinical decision support, allowing healthcare providers to calculate optimal doses, simulate predicted outcomes, and review alternative dosing regimens. The company offers a diverse range of drug models across various therapeutic areas, including infectious diseases (e.g., vancomycin), oncology, transplant medicine, cardiovascular and coagulation management, and pediatrics.

By providing a sophisticated yet intuitive tool, DoseMeRx empowers healthcare teams to move beyond traditional dosing methods, enhancing efficiency and standardizing workflows in therapeutic drug monitoring programs. The platform is HITRUST CSF certified, ensuring high standards of patient data security and integrity.

Focus Areas

Precision Bayesian dosing model-informed precision dosing (MIPD) therapeutic drug monitoring individualized dosing vancomycin dosing infectious disease oncology transplant medicine cardiovascular coagulation management pediatrics antimicrobial stewardship clinical decision support health analytics

Business Intelligence

Key InvestorsFairlong Capital (acquirer), ANDHealth, Steve Baxter, Greg Spurgin, Gary Cunningham
PartnershipsInovalon, Dot.lib, Senior Care Partners (PACE), University Medical Centre Ljubljana and University Hospital of Maribor, Physiomics plc
AcquisitionsAcquired by Fairlong Capital, LLC (January 20, 2023); Acquired Firstline (November 03, 2025)
TechnologyCloud-native, Bayesian dosing methods, clinically-validated pharmacokinetic/pharmacodynamic (PK/PD) models, integrates with EHR systems, AI-powered systems (future development), HITRUST Risk-based, 2-year (r2) certified, HIPAA compliant, ISO compliant, FDA compliant
FDA ClearancesThe platform is FDA compliant. In 2016, a submission to the FDA was being assessed. The company also holds CE (European Conformity) and TGA ARTG (Australia) regulatory clearances. cleared products (estimated)

What Physicians Need to Know

Precision Bayesian Dosing & MIPD
DoseMeRx is a leading Bayesian dosing platform that leverages clinically-validated pharmacokinetic/pharmacodynamic (PK/PD) models, patient characteristics, drug concentrations, and genotypes to accurately individualize medication doses in seconds. This model-informed precision dosing (MIPD) approach aims to optimize drug exposure for each patient, improving clinical outcomes and reducing adverse drug events.
Therapeutic Drug Monitoring (TDM)
The platform simplifies therapeutic drug monitoring by providing clinically validated drug models across various therapeutic areas. It enables accurate individualized dose calculation with a single drug level, helping to reach therapeutic targets quicker and offering real-time visualization of PK/PD.
Individualized Dosing
DoseMeRx ensures personalized dosing by considering how each individual absorbs and clears medicines, combining patient-specific information with Bayesian dose forecasting to calculate the most effective dose. This approach significantly improves the percentage of patients reaching their therapeutic target.
Vancomycin Dosing
DoseMeRx supports vancomycin AUC (Area Under the Curve) and trough/peak targets, offering two-compartment and single-compartment adult vancomycin models. It aligns with the 2020 vancomycin dosing guidelines, recommending AUC-based dosing for serious MRSA infections to reduce nephrotoxicity and can reduce the number of blood samples required.
Infectious Disease
The platform includes drug models for anti-infectives, such as vancomycin and aminoglycosides. DoseMe's acquisition of Firstline further enhances its end-to-end clinical decision support for infectious diseases and antimicrobial stewardship.
Oncology
DoseMeRx provides models for oncology therapeutics including busulfan, carboplatin, cyclosporine, imatinib mesylate, and methotrexate. It aims to optimize drug utilization, reduce toxicity, and can simplify complex dosing regimens like busulfan with fewer blood samples.
Transplant Medicine
DoseMe offers drug models specifically for transplant medicine, aiding in the precise dosing of immunosuppressants like cyclosporine.
Cardiovascular & Coagulation Management
The platform includes drug models for cardiovascular conditions and coagulation management, supporting individualized dosing in these critical areas.
Pediatrics
DoseMeRx supports pediatric dosing across various therapeutic areas, including vancomycin and oncology drugs, addressing the unique pharmacokinetic challenges in this patient population.
Antimicrobial Stewardship
DoseMeRx supports antimicrobial stewardship initiatives by optimizing antibiotic selection, dosing, and duration. This helps improve patient safety, reduce antibiotic resistance, and streamlines compliance with vancomycin AUC guidelines.
Clinical Decision Support
DoseMeRx is an easy-to-use, unique decision support software that provides real-time, evidence-based dose-related recommendations. It integrates smart technology with validated PK/PD models and patient data to guide dose optimization.
Health Analytics
DoseMe offers advanced analytics solutions like DoseMe Crunch for retrospective data analysis and DoseMe Analytics for real-time tracking of clinical outcomes and dosing practices. DoseMe Cohere further provides predictive analytics, using machine learning to identify at-risk patients for vancomycin therapy before adverse events occur.
Physician Tip

For physicians, DoseMeRx offers significant advantages by transforming complex dosing into a streamlined, evidence-based process. It allows for rapid, individualized dose calculations, reducing the risk of sub- or supra-therapeutic drug levels and associated toxicities (e.g., vancomycin-induced nephrotoxicity). The platform's ability to simulate predicted outcomes and compare them against guidelines empowers confident decision-making. By minimizing manual calculations and integrating seamlessly with EHRs, it frees up valuable time, allowing physicians to focus more on direct patient care rather than administrative tasks. Furthermore, its support for antimicrobial stewardship helps in combating antibiotic resistance and meeting regulatory requirements. The reduction in required blood samples for TDM, particularly for drugs like busulfan and vancomycin, also lessens patient discomfort and optimizes workflow.

DoseMeRx is designed for seamless integration with a wide range of hospital systems, including major Electronic Health Records (EHR) like Epic (using SMARTu00ae and FHIRu00ae technologies) and Cerner, as well as pharmacy surveillance solutions such as VigiLanz and Sentri7. This integration eliminates the need for manual data entry, automatically pulling patient data to facilitate precise dose calculations within existing clinical workflows. The implementation process is described as fast and easy, requiring minimal IT resources from the facility.

Products by DoseMe

1 product in the directory

DoseMeRx
DoseMe
Pharmacology & Dosing AI
DoseMeRx is the world’s first and largest Bayesian dosing platform, providing individualized drug doses using clinically-validated pharmacokinetic models and patient data to improve patient outcomes and lower costs.

What the Web Says

DoseMeRx is a decision support software that uses pharmacokinetic drug models, patient characteristics, drug concentrations, and genotype to optimize drug dosages. Users generally find the platform easy to use and practical, appreciating its ability to help identify correct drug dosages and save time. The company has also partnered with Cerner to integrate its precision dosing software within the Cerner EHR platform.

Overall: Positive

Strengths

  • Leverages Bayesian Approach for accurate dosage selection.
  • Easy to use and practical interface.
  • Helps identify the correct drug type for patients.
  • Saves time on billing and finding drugs for patients.
  • Integrates with Cerner EHR for real-time precision dosing.
  • Unique decision support software for dose optimization.

Limitations

  • Some users wish it could consider multiple drug use scenarios that might change dosing.
  • Limited information available on employer reviews across major platforms.
  • No specific product reviews found on Capterra or Reddit for DoseMeRx, with Reddit results primarily showing a different app called 'DoseMed'.
  • G2 only has two reviews for DoseMeRx, limiting comprehensive feedback.

Based on reviews from: G2, Becker's Hospital Review, Reddit

Last updated: 2026-08-05

Videos

News, demos, and interviews about DoseMe.

Loading videos...

Videos load interactively. If none appear, search YouTube for DoseMe →

View all on YouTube

Press & Coverage

DoseMe
Alta Vista Regional Hospital Advances Precision Antibiotic Dosing with DoseMeRx Deployment
Alta Vista Regional Hospital has implemented DoseMeRx to support consistent, evidence-based antibiotic dosing, particularly for vancomycin, aligning with evolving clinical guidelines and maximizing resources in a rural hospital setting.
2026-07
DoseMe
DoseMe Appoints Richard Malone, PharmD, MHA, as Vice President, Clinical & Science
DoseMe appointed Richard Malone as VP, Clinical & Science, to lead clinical and scientific initiatives, including biostatistics and scientific strategy, and integrate newly acquired capabilities from Firstline.
2026-03
PMC
A full educational resource review of grey literature resources for vancomycin dosing tutorials - PMC
A study evaluating educational resources for vancomycin dosing found DoseMe to be a high-quality option for 'just-in-time training' and noted its accuracy has been peer-reviewed.
2026-01
Business Wire
DoseMe Acquires Firstline to Build End-to-End Clinical Decision Support for Health Systems in the Global Fight Against Infectious Disease
DoseMe acquired Firstline, a clinical decision support platform, to create a unified solution for clinicians, streamlining the process from therapy selection to personalized dosing and combating antimicrobial resistance.
2025-11
Inovalon
Inovalon and DoseMe: Precision Dosing to Pharmacy Workflows
Inovalon collaborated with DoseMe to integrate the DoseMeRx platform with Inovalon's VigiLanz Pharmacy Surveillance solution, aiming to streamline workflows, reduce adverse drug events, and improve patient outcomes through precision dosing.
2025-10
DoseMe
DoseMe Unveils New Analytics User Interface to Power the Future of Data-Driven Precision Dosing
DoseMe launched a new analytics user interface for its Bayesian model-informed precision dosing platform, enhancing performance, clarity, and enabling faster, more actionable insights for clinicians.
2025-05
DoseMe
DoseMe Achieves HITRUST Risk-Based, 2-year (r2) Certification
DoseMe earned HITRUST Risk-based, 2-year (r2) Certification for its DoseMeRx platform, demonstrating its commitment to strong cybersecurity and protection of sensitive data.
2024-07
Business Wire
DoseMe Announces 2023 Highlights; Precision Dosing Fast-Tracking to Top Trend in 2024
DoseMe announced its 2023 company highlights, including acquisition by Fairlong Capital and executive appointments, and outlined its 2024 outlook, emphasizing the growing trend of precision dosing.
2024-01

Frequently Asked Questions

DoseMe is a leading provider of software that utilizes Precision Bayesian Dosing and Model-Informed Precision Dosing (MIPD) to individualize medication regimens. Its flagship product, DoseMeRx, employs clinically validated pharmacokinetic drug models, patient characteristics, drug concentrations, and genotype to accurately calculate optimal doses in real-time. This approach aims to achieve therapeutic targets faster, reduce adverse drug events, and improve patient outcomes by accounting for inter- and intra-patient variability.
DoseMe supports a wide range of therapeutic areas, including infectious diseases (e.g., vancomycin, aminoglycosides, antifungals), oncology (e.g., busulfan, carboplatin, methotrexate), transplant medicine, cardiovascular and coagulation management (e.g., digoxin, warfarin, enoxaparin), and pediatrics. The platform offers drug models for these areas, enabling clinicians to optimize dosing for narrow therapeutic index drugs and complex patient populations.
DoseMe significantly contributes to antimicrobial stewardship by optimizing antibiotic dosing, particularly for drugs like vancomycin, to achieve AUC-based targets and reduce the incidence of acute kidney injury. Through products like DoseMeRx and the recently acquired Firstline, it provides clinical decision support by offering local, evidence-based infectious disease treatment guidance and integrating personalized dosing recommendations directly into clinical workflows.
DoseMe's primary products include DoseMeRx for real-time precision dosing and DoseMe Analytics for tracking clinical outcomes and dosing trends. DoseMeRx integrates seamlessly with major EHR systems like Epic and Cerner using SMARTu00ae and FHIRu00ae technologies, automatically extracting patient data to streamline workflows and eliminate manual entry. DoseMe Analytics provides real-time insights into dosing practices, allowing for continuous program optimization.
DoseMe is committed to maintaining high compliance and security standards, being HIPAA, ISO, and FDA compliant, and the only Bayesian dosing platform to be HITRUST CSF certified. The company adheres to privacy frameworks like the Privacy Act 1988 (Cth) and GDPR, storing data in the appropriate jurisdictions. DoseMe employs robust data security measures, including 2048-bit SSL certificates for data transmission and role-based access controls to protect patient information.
While specific pricing details are typically provided upon inquiry, DoseMe generally offers subscription-based models for its software solutions. The company provides comprehensive implementation support, working with healthcare organizations to develop business cases, collaborate with IT teams for integration, and customize workflows. Ongoing technical assistance and customer support are available 24/7, ensuring continuous operational efficiency and user satisfaction.
DoseMe, founded in 2014 and acquired by Fairlong Capital, LLC, demonstrates stability as a global leader in MIPD software. It has formed strategic partnerships with major EHR vendors like Cerner and Epic for seamless integration, and with companies like Inovalon (VigiLanz) to enhance pharmacy surveillance workflows. Additionally, DoseMe has expanded its global reach through reseller agreements and collaborations aimed at advancing antimicrobial stewardship and precision dosing.

Related Companies

Drugs.com is a leading independent online pharmaceutical encyclopedia providing comprehensive, accurate, and objective information on over 24,000 prescription drugs, over-the-counter medicines, and natural products. The platform serves both consumers and healthcare professionals, aiming to empower patients with knowledge for better self-management of healthcare and to improve consumer safety by reducing medication errors. For physicians, Drugs.com […]

Nirmitee.io is a healthcare AI company that specializes in digital engineering for the life sciences sector. They focus on designing, building, and scaling secure, compliant AI products for teams involved in clinical research, medical affairs, commercial operations, evidence generation, and healthcare delivery. [2] The company aims to bridge the gap between advanced AI technology and […]

CoverMyMeds is a leading healthcare technology company dedicated to simplifying medication access for patients by streamlining complex administrative processes. For physicians, their platform primarily automates the prior authorization (PA) process for prescription drugs, aiming to reduce the significant time and paperwork traditionally associated with obtaining insurance approvals. This integration with electronic health record (EHR) systems […]

Clair Health is an innovative healthcare AI company dedicated to revolutionizing women’s health through its pioneering non-invasive continuous hormone tracker. The company leverages advanced sensor fusion and deep learning models, trained on diverse female physiology, to continuously monitor key reproductive hormones such as estrogen, progesterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) via a wrist-worn […]

AXIFI is an AI-powered clinical intelligence platform designed to democratize access to medical research and clinical knowledge, particularly within longevity medicine. The platform synthesizes millions of research papers, clinical trials, and real-world data to provide evidence-graded insights rapidly. For physicians, AXIFI offers a comprehensive suite of tools including an AI Scribe for real-time clinical documentation […]

SyncMed is an early-stage healthcare AI company focused on transforming medication reconciliation through its AI-powered conversational platform. The company aims to improve patient safety, reduce medication errors, and streamline clinical workflows by intelligently gathering and reconciling patient medication data. Their technology is designed to translate a pharmacist’s expertise and workflow into an advanced computer program, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.